F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim
New Investment from Forbion and Sofinnova Partners
QUANTRO Therapeutics collaborates with Boehringer Ingelheim to develop drug candidates interfering with transcriptional regulators
QUANTRO Therapeutics today announced that they have entered a three-year collaboration, option and license agreement…
Biosynth Carbosynth to offer Enzyme Development following Acquisition of EUCODIS Bioscience
Expanded biological products and custom services offer for Life Science customers.
AOP Health erforscht ab sofort neue Behandlungsmöglichkeiten für Leukämie
Die Unternehmensgruppe AOP Health hat im Juli eine Vereinbarung für die Weiterentwicklung einer neu entdeckten…
Boehringer Ingelheim errichtet neues Forschungsgebäude in Wien
- Spatenstich am 26. Juli – Fertigstellung geplant für 2024
- Investitionsvolumen rund 60 Mio. EUR
- Stärkung des…
UpNano: 2PP 3D-Printing: Fresh capital boosts innovation and use in serial production
UpNano further strengthens R&D and US expansion with capital increase
Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001
VLA2001 becomes the first COVID-19 vaccine to receive a standard marketing authorization in Europe
Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders
Proxygen, a leader in the discovery and development of molecular glue degraders, announced today that the company has…
BMDW: Schramböck: 50 Millionen Euro Investitionspaket für den heimischen Pharmastandort
FFG wird 50 Millionen Euro starkes Programm umsetzen - Österreichische Betriebe forschen für die Gesundheit Österreichs
Wiener Life-Science-Unternehmen Valneva präsentiert Corona-Impfstoff aus Wien
13,3 Milliarden Umsatz, 600 ansässige Organisationen und 41.000 Arbeitsplätze: Das sind die aktuellsten Kennzahlen der…
CellEctric closes first financing round with IST cube and other private investors
The Viennese spin-off from AIT Austrian Institute of Technology develops an electrodynamic cell manipulation platform…
Roche subsidiary RoX Health invests six-figure sum in Viennese healthtech start-up XUND
XUND combines medical knowledge with proven algorithms to create high-quality solutions for the digital health market.…